$25.41
-0.56[-2.16%]
At close: Apr 23
$25.41
0[0.00%]
After Hours: 4:00PM EDT
PTC Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of PTC Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
04/25/2024 | PM | PTCT | Q1 | -$1.88 | -$1.25 | — | — | $220.38M | $170.36M | — | — | Get Alert |
02/29/2024 | PM | PTCT | Q4 | -$1.89 | $0.50 | -$0.24 | -148.00% | $167.41M | $321.29M | $307.06M | -4.43% | Get Alert |
10/26/2023 | PM | PTCT | Q3 | -$1.53 | -$1.17 | -$1.76 | -50.43% | $217.13M | $210.19M | $196.58M | -6.48% | Get Alert |
08/03/2023 | PM | PTCT | Q2 | -$2.13 | -$1.58 | -$1.48 | 6.33% | $165.53M | $213.95M | $213.81M | -0.07% | Get Alert |
04/27/2023 | PM | PTCT | Q1 | -$1.78 | -$1.39 | -$1.88 | -35.25% | $148.74M | $182.62M | $220.38M | 20.68% | Get Alert |
02/21/2023 | PM | PTCT | Q4 | -$2.03 | -$1.59 | -$1.89 | -18.87% | $165.23M | $189.14M | $167.41M | -11.49% | Get Alert |
10/27/2022 | PM | PTCT | Q3 | -$1.89 | -$1.19 | -$1.53 | -28.57% | $138.74M | $186.90M | $217.13M | 16.17% | Get Alert |
08/04/2022 | PM | PTCT | Q2 | -$1.68 | -$1.33 | -$2.13 | -60.15% | $116.68M | $162.09M | $165.53M | 2.12% | Get Alert |
05/03/2022 | PM | PTCT | Q1 | -$1.83 | -$1.51 | -$1.78 | -17.88% | $117.94M | $147.06M | $148.74M | 1.14% | Get Alert |
02/22/2022 | PM | PTCT | Q4 | -$1.08 | -$1.64 | -$2.03 | -23.78% | $118.86M | $150.83M | $165.23M | 9.55% | Get Alert |
10/28/2021 | PM | PTCT | Q3 | -$1.03 | -$1.40 | -$1.89 | -35.00% | $118.40M | $126.44M | $138.74M | 9.73% | Get Alert |
07/29/2021 | PM | PTCT | Q2 | -$2.62 | -$1.82 | -$1.68 | 7.69% | $75.24M | $110.50M | $116.68M | 5.59% | Get Alert |
05/04/2021 | PM | PTCT | Q1 | -$1.81 | -$1.51 | -$1.83 | -21.19% | $68.26M | $98.80M | $117.94M | 19.37% | Get Alert |
02/25/2021 | PM | PTCT | Q4 | -$1.37 | -$0.94 | -$1.08 | -14.89% | $96.46M | $111.36M | $118.86M | 6.74% | Get Alert |
10/29/2020 | PM | PTCT | Q3 | -$1.06 | -$0.04 | -$1.03 | -2475.00% | $71.42M | $111.88M | $118.40M | 5.83% | Get Alert |
08/05/2020 | PM | PTCT | Q2 | -$0.75 | -$1.30 | -$2.62 | -101.54% | $85.52M | $82.78M | $75.24M | -9.11% | Get Alert |
04/30/2020 | PM | PTCT | Q1 | -$1.29 | -$1.31 | -$1.81 | -38.17% | $53.58M | $81.94M | $68.26M | -16.70% | Get Alert |
03/02/2020 | PM | PTCT | Q4 | -$0.58 | -$0.51 | -$1.37 | -168.63% | $86.34M | $95.24M | $96.46M | 1.28% | Get Alert |
10/29/2019 | PM | PTCT | Q3 | -$1.06 | -$0.76 | -$1.06 | -39.47% | $53.59M | $73.02M | $71.42M | -2.20% | Get Alert |
PTC Therapeutics (PTCT) is scheduled to report earnings on April 25, 2024. The last reported earnings were for reported on February 29, 2024 for Q4.
The Actual EPS was $-0.24, which missed the estimate of $0.50.
The Actual Revenue was $307.1M, which missed the estimate of $321.3M.
Browse earnings estimates, EPS, and revenue on all stocks.